Table 3 Overall study results, comparing Pregvit^® (low iron) to Materna^® (high iron) over a month administration in a cross-over design.

Pill Count (% of 100%)

78

87.7 ± 20

90.9 ± 17

0.11

Reported Compliance (%)

138

90.4 ± 18

92.4 ± 15

0.42

Adverse events (%)

138

17.6 ± .24

20.3 ± 24

0.14

Nausea (%)

138

9.3 ± 19

10.1 ± 18

0.71

Constipation time length (%)

138

3.1 ± 8

4.7 ± 11

0.05

Other adverse events

138 (n)

10.4 ± 21

99.9 ± 20

0.95

Nausea rate (%)

138

41.3 (57/81)

45.7 (63/75)

0.54

Constipation Rate (%)

138

22.5% (31/107)

34.8% (48/90)

0.03